CDC Updates Testing and Management Considerations and Reinfection Criteria COVID-19; Programs and Resources Published:November 23, 2020 COVID19@ahca.org Rollup Image Page ContentThe Centers for Disease Control and Prevention (CDC) released updates to testing and management considerations for nursing home residents with acute respiratory illness symptoms when COVID-19 and influenza viruses are co-circulating. The CDC says that the following practices should be considered when both COVID-19 and influenza viruses are found in the community based upon local health surveillance data and testing at local healthcare facilities. The considerations are specific to nursing home resident care but could be adapted for use in other long-term care settings including assisted living facilities. The CDC released criteria on COVID-19 cases that should be assessed for suspected reinfection. The criteria outlines standards that laboratory testing should meet when evaluating specimens for reinfection. The CDC issued a protocol intended to provide state/local health departments with standardized framework and toolkit for investigating COVID-19 reinfection suspected cases. Please visit the new reinfection webpages to learn more: Common Investigation Protocol for Investigating Suspected SARS-CoV-2 Reinfection Investigative Criteria for Suspected Cases of SARS-CoV-2 Reinfection (ICR) Reinfection with COVID-19 (consumer website companion) Related Blogs Associate Business Member of the Month: Cardinal Health 10.4.2024 Honoring Infection Prevention Champions in Long Term Care 10.1.2024 New NHSN LTCF Respiratory Pathogens & Vaccination Module is Live 10.1.2024